The global molecule diagnostic market is expected to grow with a CAGR of 9% by 2024


   January 3, 2022
According to a new market report published by Lucintel, the future of the molecule diagnostic market looks promising with opportunities in the reference laboratories, and hospital/academic laboratories. The global molecule diagnostic market is expected to grow with a CAGR of 9% from 2019 to 2024. The major drivers for this market are high prevalence of infectious diseases and various types of cancer, increasing awareness and acceptance of personalized medicine and companion diagnostic, growth in the biomarker identification market and advancements in molecular techniques, and reforms in the reimbursement system in the US.

In this market, assays and kits, instruments/analyzers, and services & software are the major product type.

Infectious diseases, oncology, genetic tests, blood screening, and microbiology are the major application of the global molecule diagnostic market. The infectious diseases segment is expected to account for the largest share of the global molecular diagnostics market.

North America will remain the largest region over the forecast period due to easy accessibility to technologically advanced instruments, and availability of government funds.

Abbott Laboratories, Qiagen, Roche Diagnostic, Hologic, Grifols, Siemens Healthcare, Becton, Dickinson and Company, Beckman Coulter, Biomérieux, and Cepheid are among the major manufacturers of molecule diagnostic market.

Lucintel, a leading global strategic consulting and market research firm, has analyzed growth opportunities in the global molecule diagnostic market by product and services, application, technology, end user, and region. Lucintel has prepared a comprehensive research report entitled "Global Molecular Diagnostic Market 2019-2024: Trends, Forecast, and Opportunity Analysis". This Lucintel report serves as a catalyst for growth strategy as it provides comprehensive data and analysis on trends, key drivers, and directions. The study includes a forecast for the global molecule diagnostic market by product and services, application, technology, end user, and by region as follows:

By Product and Service [$M shipment analysis for 2013 – 2024]:



  • Assays and Kits


  • Instruments/Analyzers


  • Services and Software


By Application [$M shipment analysis for 2013 – 2024]:



  • Infectious Diseases


  • Oncology


  • Genetic Tests


  • Blood Screening


  • Microbiology


  • Others


By Technology [$M shipment analysis for 2013 – 2024]:



  • PCR


  • INAAT


  • DNA Sequencing & NGS


  • In Situ Hybridization


  • DNA Microarrays


  • Other Technologies


 By End User [$M shipment analysis for 2013 – 2024]:



  • Reference Laboratories


  • Hospital/Academic Laboratories


  • Others


 

By Region [$M shipment analysis for 2013 – 2024]:



  • North America




  • United States


  • Canada


  • Mexico




  • Europe




  • United kingdom


  • Germany


  • France


  • Italy


  • Spain




  • Asia-Pacific




  • China


  • India


  • Japan




  • Rest of the World (ROW)




  • Brazil


 

This research report of more than 150 pages will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or click on this link…… or helpdesk@lucintel.com.

About Lucintel

Lucintel, the premier global Management Consulting and market research firm, creates winning strategies for growth. It offers market assessments, competitive analysis, opportunity analysis, Growth Consulting, M&A, and Due diligence services to executives and key decision-makers in a variety of industries. For further information, visit www.lucintel.com.



Lucintel Corporate Customers

Market Entry, M & A, Opportunity Screening,...

Private Equity Customers

Buy Side Services (target screening, due diligence, ..)

Customer Quotes

"With more than 20 years experience in the industry, this is the first time we have come across such an extensive market analysis for our industry." Ven Cote, CEO, ZCL

"The insights we gained from Lucintel work helped with our business plan…a wonderful professional job…" Mike Jackson, Stahlin

"The report from Lucintel is useful not only for business planners, but also for the technology officers wanting to create a roadmap …" Dr. Giulio Ranzo, Booz Allen

"The information is so comprehensive, it has allowed us to identify & focus our business development efforts. It saved months of leg-work." Bill Barz, L&L Products

"We bought Lucintel report because it is the best report about our industry…a complete and appropriate analysis." Cesare Andrenacci, Ferretti